DK1200447T3 - Oxazinocarbazoler til behandling af CNS-sygdomme - Google Patents
Oxazinocarbazoler til behandling af CNS-sygdommeInfo
- Publication number
- DK1200447T3 DK1200447T3 DK00948738T DK00948738T DK1200447T3 DK 1200447 T3 DK1200447 T3 DK 1200447T3 DK 00948738 T DK00948738 T DK 00948738T DK 00948738 T DK00948738 T DK 00948738T DK 1200447 T3 DK1200447 T3 DK 1200447T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxazinocarbazoles
- treatment
- cns diseases
- cns
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14601399P | 1999-07-28 | 1999-07-28 | |
| PCT/US2000/019532 WO2001009142A1 (en) | 1999-07-28 | 2000-07-20 | Oxazinocarbazoles for the treatment of cns diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1200447T3 true DK1200447T3 (da) | 2004-02-02 |
Family
ID=22515535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00948738T DK1200447T3 (da) | 1999-07-28 | 2000-07-20 | Oxazinocarbazoler til behandling af CNS-sygdomme |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6448397B1 (da) |
| EP (1) | EP1200447B1 (da) |
| JP (1) | JP2003506328A (da) |
| KR (1) | KR20020015079A (da) |
| CN (1) | CN1165539C (da) |
| AR (1) | AR024963A1 (da) |
| AT (1) | ATE251167T1 (da) |
| AU (1) | AU767282B2 (da) |
| BR (1) | BR0012791A (da) |
| CA (1) | CA2376927A1 (da) |
| CO (1) | CO5031298A1 (da) |
| DE (1) | DE60005685T2 (da) |
| DK (1) | DK1200447T3 (da) |
| ES (1) | ES2208371T3 (da) |
| MX (1) | MXPA02000984A (da) |
| PE (1) | PE20010548A1 (da) |
| PT (1) | PT1200447E (da) |
| TW (1) | TWI222450B (da) |
| WO (1) | WO2001009142A1 (da) |
| ZA (1) | ZA200110539B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100497122B1 (ko) * | 2001-08-30 | 2005-06-29 | 주식회사 삼양제넥스 | 페놀옥시다제 시스템을 구성하는 단백질 및 그것의 유전자 |
| SE0103539D0 (sv) * | 2001-10-23 | 2001-10-23 | Biovitrum Ab | New Use |
| DE60232173D1 (de) * | 2001-11-09 | 2009-06-10 | Biovitrum Ab Publ | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme |
| US6932961B1 (en) | 2002-04-16 | 2005-08-23 | Pharmacia & Upjohn Company | Oxazinocarbazoles for the treatment of CNS diseases |
| JP2005537226A (ja) * | 2002-04-16 | 2005-12-08 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 診断薬としての標識オキサジノカルバゾール |
| PL377464A1 (pl) * | 2002-12-03 | 2006-02-06 | F. Hoffmann-La Roche Ag | Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN |
| EP2004659A1 (en) * | 2006-04-12 | 2008-12-24 | Wyeth | Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0297651B1 (en) * | 1987-06-29 | 1993-11-03 | Duphar International Research B.V | Anellated indole derivatives |
| GB8812636D0 (en) | 1988-05-27 | 1988-06-29 | Glaxo Group Ltd | Chemical compounds |
| EP0377238A1 (en) * | 1988-12-22 | 1990-07-11 | Duphar International Research B.V | New annelated indolo (3,2-c)-lactams |
| WO1995011245A1 (fr) | 1993-10-20 | 1995-04-27 | Tokyo Tanabe Company Limited | Derive d'indole |
| US6018046A (en) | 1996-05-31 | 2000-01-25 | Mochida Pharmaceutical Co., Ltd. | Pyridocarbazole derivatives having cGMP-PDE inhibitory activity |
-
2000
- 2000-07-19 TW TW089114437A patent/TWI222450B/zh active
- 2000-07-20 JP JP2001513949A patent/JP2003506328A/ja active Pending
- 2000-07-20 DE DE60005685T patent/DE60005685T2/de not_active Expired - Fee Related
- 2000-07-20 DK DK00948738T patent/DK1200447T3/da active
- 2000-07-20 AT AT00948738T patent/ATE251167T1/de not_active IP Right Cessation
- 2000-07-20 US US09/620,493 patent/US6448397B1/en not_active Expired - Fee Related
- 2000-07-20 EP EP00948738A patent/EP1200447B1/en not_active Expired - Lifetime
- 2000-07-20 BR BR0012791-4A patent/BR0012791A/pt not_active IP Right Cessation
- 2000-07-20 ES ES00948738T patent/ES2208371T3/es not_active Expired - Lifetime
- 2000-07-20 CA CA002376927A patent/CA2376927A1/en not_active Abandoned
- 2000-07-20 PT PT00948738T patent/PT1200447E/pt unknown
- 2000-07-20 AU AU62197/00A patent/AU767282B2/en not_active Ceased
- 2000-07-20 KR KR1020027001118A patent/KR20020015079A/ko not_active Application Discontinuation
- 2000-07-20 WO PCT/US2000/019532 patent/WO2001009142A1/en not_active Application Discontinuation
- 2000-07-20 MX MXPA02000984A patent/MXPA02000984A/es active IP Right Grant
- 2000-07-20 CN CNB008104573A patent/CN1165539C/zh not_active Expired - Fee Related
- 2000-07-25 PE PE2000000747A patent/PE20010548A1/es not_active Application Discontinuation
- 2000-07-26 CO CO00056117A patent/CO5031298A1/es unknown
- 2000-07-27 AR ARP000103887A patent/AR024963A1/es unknown
-
2001
- 2001-12-21 ZA ZA200110539A patent/ZA200110539B/xx unknown
-
2002
- 2002-05-16 US US10/146,970 patent/US6821970B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6821970B2 (en) | 2004-11-23 |
| WO2001009142A1 (en) | 2001-02-08 |
| EP1200447B1 (en) | 2003-10-01 |
| PE20010548A1 (es) | 2001-05-13 |
| CN1165539C (zh) | 2004-09-08 |
| ATE251167T1 (de) | 2003-10-15 |
| ZA200110539B (en) | 2003-03-24 |
| US6448397B1 (en) | 2002-09-10 |
| CO5031298A1 (es) | 2001-04-27 |
| TWI222450B (en) | 2004-10-21 |
| US20020169317A1 (en) | 2002-11-14 |
| EP1200447A1 (en) | 2002-05-02 |
| JP2003506328A (ja) | 2003-02-18 |
| ES2208371T3 (es) | 2004-06-16 |
| MXPA02000984A (es) | 2002-07-30 |
| KR20020015079A (ko) | 2002-02-27 |
| CA2376927A1 (en) | 2001-02-08 |
| DE60005685D1 (de) | 2003-11-06 |
| BR0012791A (pt) | 2002-06-18 |
| AR024963A1 (es) | 2002-10-30 |
| CN1361781A (zh) | 2002-07-31 |
| AU767282B2 (en) | 2003-11-06 |
| PT1200447E (pt) | 2004-02-27 |
| DE60005685T2 (de) | 2004-08-12 |
| AU6219700A (en) | 2001-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
| DK1259512T3 (da) | Pteridinforbindelser til behandling af psoreasis | |
| DK1343773T3 (da) | Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser | |
| DK1028954T3 (da) | Substituerede imidazoler egnede til behandling af inflammatoriske sygdomme | |
| DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
| IS7099A (is) | Efnasambönd til að meðhöndla bólgutruflanir | |
| NO20012995L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| NO20031443D0 (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| FI20000564A (fi) | Menetelmä nanolaminaattien valmistamiseksi | |
| DK0967214T3 (da) | Intranasale formuleringer til behandling af seksuelle forstyrrelser | |
| DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
| DK1562932T3 (da) | 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter | |
| DK1165576T3 (da) | Fremgangsmåde til fremstilling af amin-platin-komplekser | |
| DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
| DK1150991T3 (da) | Præparater til behandling af inflammatoriske reaktioner | |
| DK1176964T3 (da) | Brug af ET743 til behandling af cancer | |
| DK1392318T3 (da) | 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse | |
| DK1344526T3 (da) | Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser | |
| DK1468996T3 (da) | Indolderivater til behandling af CNS-sygdomme | |
| DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
| DK1200114T3 (da) | PPAR delta inhibitorer til behandling af kardiovaskulære sygdomme | |
| DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
| DK1121356T3 (da) | 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser | |
| DK1225890T3 (da) | Rivastigmin til behandling af öjensygdomme | |
| NO20030717D0 (no) | Forbindelser for behandling av avhengighetsforstyrrelser |